Mineralys Therapeutics (MLYS) Net Income
Price: $13.56
Market Cap: $879.72M
Avg Volume: 1.14M
Market Cap: $879.72M
Avg Volume: 1.14M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
What is Mineralys Therapeutics's Net Income?
- Mineralys Therapeutics's annual net income as of FY 2024 is $-177.81M.
- Mineralys Therapeutics's quarterly net income as of Q4 2024 is $-48.95M.
What is Net Income?
Net income is the total profit of a company after all expenses and taxes have been deducted from revenue. It is also known as net profit or net earnings and is a key indicator of a company's financial performance and profitability.
Related Metrics
Other important metrics to assess Mineralys Therapeutics's financial health include:
- Net Income Growth - the rate at which a company's net income is growing:
- Annual Growth: -147.31%
- Net Income Ratio - net income divided by revenue:
- Annual: -
- Quarterly: -
- Net Income Per Share - net income divided by the number of shares outstanding:
- Annual: $-3.66
These metrics provide insights into Mineralys Therapeutics's financial health and its profitability. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Net Income
$-177.81M
Quarterly Net Income
$-48.95M
Historical Annual Net Income
Historical Quarterly Net Income
Annual Net Income Growth
Annual Net Income Per Share
Mineralys Therapeutics Historical Net Income Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Net Income | Net Income Growth | Net Income Ratio | Net Income Per Share |
|---|---|---|---|---|
| 2024 | $-177.81M | -147.31% | - | $-3.66 |
| 2023 | $-71.90M | -141.28% | - | $-1.99 |
| 2022 | $-29.80M | -53.54% | - | $-0.73 |
| 2021 | $-19.41M | -466.49% | - | $-0.50 |
| 2020 | $-3.43M | 0.00% | - | $-0.09 |